Omeros | OMER - Loan Capital

Stock Price
11.56
Daily Change
-0.03 -0.26%
Monthly
2.94%
Yearly
54.65%
Q1 Forecast
11.68

Omeros reported $403.72M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Adma Biologics USD 70.08M 3.32M Sep/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Immunic USD 0 0 Jun/2024
Insmed USD 540.96M 1.24M Dec/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
MacroGenics USD 70.26M 4K Sep/2025
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 372.19M 4.53M Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Rockwell Medical USD 8.65M 89K Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Xoma USD 94.38M 7.82M Sep/2025